Literature DB >> 8360268

Deregulation of cyclins D1 and E and suppression of cdk2 and cdk4 in senescent human fibroblasts.

F C Lucibello1, A Sewing, S Brüsselbach, C Bürger, R Müller.   

Abstract

The state of cellular senescence is characterised by an irreversible arrest in the G1 phase of the cell cycle. It has previously been shown that three cell cycle genes, cyclin A, cyclin B and cdc2, are not expressed in senescent human fibroblasts. All three gene products have functions after S-phase entry, so that their suppression cannot explain the irreversible G1 arrest. Here, we report that the abundance of transcripts from two other cell cycle genes, cdk2 and cdk4, thought to act during G1-->S progression, is significantly diminished in senescent cells of the diploid human fibroblast line WI-38. Surprisingly, two other cyclins, D1 and E, behave in a completely different way, in that their expression is elevated in senescent cells, especially under conditions of serum starvation. Both the synthesis and the steady-state level of cyclin D1 protein were also found to be markedly higher in senescent cells (3- to 6-fold). Cyclins D1 and E are thus the first genes shown to be overexpressed or deregulated in senescent cells. It is tempting to speculate that this deregulation may be due to the absence, in senescent cells, of a regulatory loop that would normally control their expression. This is supported by our finding that cyclin E-associated kinase activity in senescent cells is reduced approx. 14-fold. Our data also suggest that the deregulated expression of cyclin D1 and E is not sufficient to drive senescent cells into DNA replication.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8360268     DOI: 10.1242/jcs.105.1.123

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  31 in total

1.  High-intensity Raf signal causes cell cycle arrest mediated by p21Cip1.

Authors:  A Sewing; B Wiseman; A C Lloyd; H Land
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

2.  Increased expression of cyclin D2 during multiple states of growth arrest in primary and established cells.

Authors:  M Meyyappan; H Wong; C Hull; K T Riabowol
Journal:  Mol Cell Biol       Date:  1998-06       Impact factor: 4.272

Review 3.  Cell cycle, cytoskeleton dynamics and beyond: the many functions of cyclins and CDK inhibitors.

Authors:  Nawal Bendris; Bénédicte Lemmers; Jean Marie Blanchard
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

4.  Analysis of p53 mutation and cyclin D1 expression in breast tumors.

Authors:  J Tanyi; K Tory; A Bánkfalvi; W Shröder; W Rath; L Füzesi
Journal:  Pathol Oncol Res       Date:  1999       Impact factor: 3.201

5.  Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence.

Authors:  E Hara; R Smith; D Parry; H Tahara; S Stone; G Peters
Journal:  Mol Cell Biol       Date:  1996-03       Impact factor: 4.272

6.  Repression of cyclin D1: a novel function of MYC.

Authors:  A Philipp; A Schneider; I Väsrik; K Finke; Y Xiong; D Beach; K Alitalo; M Eilers
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

7.  Nuclear accumulation of cyclin D1 following long-term fractionated exposures to low-dose ionizing radiation in normal human diploid cells.

Authors:  Tsutomu Shimura; Nobuyuki Hamada; Megumi Sasatani; Kenji Kamiya; Naoki Kunugita
Journal:  Cell Cycle       Date:  2014-02-14       Impact factor: 4.534

8.  Structure and cell cycle-regulated transcription of the human cyclin A gene.

Authors:  B Henglein; X Chenivesse; J Wang; D Eick; C Bréchot
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

9.  Nuclear accumulation of glycogen synthase kinase-3 during replicative senescence of human fibroblasts.

Authors:  Jaroslaw W Zmijewski; Richard S Jope
Journal:  Aging Cell       Date:  2004-10       Impact factor: 9.304

10.  Proteinopathy-induced neuronal senescence: a hypothesis for brain failure in Alzheimer's and other neurodegenerative diseases.

Authors:  Todd E Golde; Victor M Miller
Journal:  Alzheimers Res Ther       Date:  2009-10-12       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.